AzTrials
AzTrials

ColonoscopyPREPA-CONCT02712073

Predictive Score of the Bowel Preparation Quality Based on a Self-administered Questionnaire

An observational study of Colonoscopy, run by University Hospital, Angers at 4 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In France, nearly 1.3 million colonoscopies are performed each year. Colonoscopy is the gold standard in France for colorectal cancer screening in populations at risk. However, it has a number of limitations. The quality of the bowel preparation is a critical step for the successful completion of this examination. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colonoscopy
What is being tested?
Questionnaire
How many people
1,260 participants
Where
4 sitesFrance
Study dates
May 2015to Sep 2017
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients seen in precolonoscopy consultation

Who may be able to join

  • Men or woman > 18 years old
  • Patient agreeing to participate in the study
  • Prescription of a bowel preparation respecting the marketing authorization.

Who cannot join

  • Major patient under guardianship, or protected person,
  • Pregnant woman,
  • Patient who doesn't understand French or can't read
  • People not affiliated with a social security scheme or of such a scheme

Trial locations and contacts

4 sites in 1 country.

Elodie Cesbron-Métivier, MD contact

+33241356054

ElMetivier@chu-angers.fr

France4 sites, 4 recruiting
  • Angers UH

    Angers

    Elodie Cesbron-Métivier, MD, +33241356054, ElMetivier@chu-angers.fr

    Nathanaëlle Cornet, +33241356054, nathanaelle.cornet@chu-angers.fr

    Recruiting
  • Cholet hospital

    Cholet

    Mehdi Kaassis

    Not yet recruiting
  • La Roche sur Yon hospital

    La Roche-sur-Yon

    Morgane Amil

    Not yet recruiting
  • Nantes UH

    Nantes

    Emmanuel Coron, MD

    Not yet recruiting

Other trials in France

About this study

In France, nearly 1.3 million colonoscopies are performed each year. Colonoscopy is the gold standard in France for colorectal cancer screening in populations at risk. However, it has a number of limitations. The quality of the bowel preparation is a critical step for the successful completion of this examination. The occurrence of interval cancers raises the problem of missed lesions. A literature review showed that there were differences between the endoscopy units on quality standards for bowel preparation. The rate of unprepared colonoscopy is estimated between 20 to 40% . In a recent cohort study, 28% of 2516 colonoscopies had a score of Boston of less than or equal to 6. These colonoscopies generate substantial additional costs to redo colonoscopies, estimated at 35 million euros in 2008. The establishment a predictive score for quality of bowel preparation based on a self-administered questionnaire completed by patients during the pre-colonoscopy consultation, would help identify patients at risk of poor preparation in order to optimize the prescribed preparation in this consultation.

Conditions
Colonoscopy
Being tested
Questionnaire

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnaireOther

    Self administered questionnaire to evaluate the preparation quality of colonoscopy

Study groups in NCT02712073
Study groupRoleWhat they receive
patients undergoing colonoscopyNot described
Receives: Other: Questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Score performance

    score performance to predict a poor bowel preparation (defined by a score of Boston inferior or equal to 7 and / or a segment equal to 1)

    Measured: within 6 month

Secondary outcomes (2)
  1. acceptability of questionnaire

    Acceptability of the questionnaire evaluated by the rate of return of the questionnaires and the rate of well completed questionnaires

    Measured: end of study

  2. Adenoma detection

    adenoma detection rate compared to Boston score

    Measured: within 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2016 (estimated)
  2. Study startMay 2015
  3. Primary completionSep 2017 (estimated)
  4. Study completionSep 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,260 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02712073
Sponsor's protocol ID
DRCI V11 01/01/2015
Acronym
PREPA-CO
Status last verified
Apr 2016
First submitted
14 Mar 2016
Last updated
13 Apr 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Colonoscopy, run by University Hospital, Angers at 4 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 13 Apr 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Elodie Cesbron-Métivier, MD (+33241356054, ElMetivier@chu-angers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Score performance (time frame: within 6 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in